I believe that these companies are going to generate massive, incredible, phenomenal stock market winners … with thousands of percent in returns.#OnceInALifetime #Opportunity #OutdatedTech #Technology #Dividends #Stocks #Investing #StockMarkethttps://t.co/JlVsueIARt
— Paul Mampilly (@Paul_M_Guru) February 22, 2018
Paul Mampilly has always been a calculated risk-taker, and looking back on his more than two and half decades of investing, he sees it has paid off. Mampilly spent many years making money for Wall Street clients, and he believes in taking chances when the odds favor your investment. In 1991, he started working on Wall Street with Deutsche Bank as a research assistant but soon found himself working with ING and Bankers Trust where he managed accounts with millions of dollars in them. Kinetics Asset Management eventually hired him, and he took their $6 billion hedge fund to a value of $25 billion. He helped the company to receive the title of one of the “World’s Best” funds by Barron’s for his work. Follow Paul Mampilly on Twitter.
When Paul Mampilly took part in the Templeton Foundation’s investment competition, he was tasked to work with $50 million to see what he could do with it. In one year he was able to bring the total of the original $50 million investment to $88 million, which is a 76% return. This was accomplished during the economic crisis of the late 2000’s, and he didn’t make any risky bets or short stocks to make it happen. After Mampilly won the competition, his popularity soared and he was asked to come on several televised media outlets including Bloomberg TV, Fox Business News, and CNBC.
In 2012, Paul Mampilly invested in Sarepta Therapeutics while it was still in its early stages as a company working to create a drug that could treat muscular dystrophy. After staying invested for many months, he sold the stock for a gain of 2,539%. On top of this successful investment, he chose to invest in Netflix and sold for a gain of 634% in 2010. Mampilly also made out by investing in OLED Universal Display Corporation, Ariad Pharmaceuticals, Stratasys, Facebook, Sciences Corporation, Whole Foods, Olympus Corporation, Grifols, and Cemex for a combined gain of 6,220%. Learn more about Paul Mampilly at stocktwits.com
Paul Mampilly now works to help the common American find their fortune in the investing world, and he works with Banyan Hill Publishing to do so. Not only is he the writer for Profits Unlimited as well as a weekly contributor to the Winning Investor Daily, but he also is the manager of the elite trading services True Momentum and Extreme Fortunes. His recommendations have led to plenty of profit for new and seasoned investors, alike, and he plans on continuing to help regular people make the fortunes they seek. View: https://www.linkedin.com/in/paulmampilly